These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 31580467)
1. Relationship of Visceral Fat and Adipokines with Cardiometabolic Diseases in Psoriasis. Goolam Mahyoodeen N; Crowther NJ; Pillay L; Snyman T; Toman M; Daya S; Tikly M Acta Derm Venereol; 2019 Dec; 99(13):1218-1223. PubMed ID: 31580467 [TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk. Toussirot E; Aubin F; Desmarets M; Wendling D; Augé B; Gillard J; Messica O; Guillot X; Laheurte C; Monnet E; Dumoulin G Rheumatology (Oxford); 2021 Jun; 60(6):2816-2825. PubMed ID: 33232483 [TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. You T; Nicklas BJ; Ding J; Penninx BW; Goodpaster BH; Bauer DC; Tylavsky FA; Harris TB; Kritchevsky SB J Gerontol A Biol Sci Med Sci; 2008 Apr; 63(4):414-9. PubMed ID: 18426966 [TBL] [Abstract][Full Text] [Related]
4. Complement C3 as a marker of cardiometabolic risk in psoriasis. Torres T; Bettencourt N; Mendonça D; Vasconcelos C; Silva BM; Selores M Arch Dermatol Res; 2014 Sep; 306(7):653-60. PubMed ID: 24848273 [TBL] [Abstract][Full Text] [Related]
5. Abdominal fat radiodensity, quantity and cardiometabolic risk: The Multi-Ethnic Study of Atherosclerosis. Shah RV; Allison MA; Lima JA; Abbasi SA; Eisman A; Lai C; Jerosch-Herold M; Budoff M; Murthy VL Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):114-22. PubMed ID: 26817938 [TBL] [Abstract][Full Text] [Related]
6. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910 [TBL] [Abstract][Full Text] [Related]
7. Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study. Lin IC; Heck JE; Chen L; Feldman SR Am J Clin Dermatol; 2021 Sep; 22(5):719-730. PubMed ID: 33913115 [TBL] [Abstract][Full Text] [Related]
8. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Saito T; Murata M; Otani T; Tamemoto H; Kawakami M; Ishikawa SE Endocr J; 2012; 59(1):39-45. PubMed ID: 22019947 [TBL] [Abstract][Full Text] [Related]
9. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis. Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis is the independent factor for early atherosclerosis: A prospective study of cardiometabolic risk profile. Dinić M; Zečević RD; Hajduković Z; Mijušković M; Đurić P; Jović Z; Grdinić A; Petrović M; Terzić B; Pejović J; Kandolf-Sekulović L Vojnosanit Pregl; 2016 Dec; 73(12):1094-1101. PubMed ID: 29341565 [TBL] [Abstract][Full Text] [Related]
11. Factors influencing cardiometabolic risk profile in patients with psoriasis. Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341 [TBL] [Abstract][Full Text] [Related]
12. Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes. Bilgir O; Gökçen B; Bilgir F; Guler A; Calan M; Yuksel A; Aslanıpour B; Akşit M; Bozkaya G Am J Med Sci; 2018 Jan; 355(1):37-43. PubMed ID: 29289260 [TBL] [Abstract][Full Text] [Related]
13. The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment. Olarescu NC; Heck A; Godang K; Ueland T; Bollerslev J Neuroendocrinology; 2016; 103(3-4):197-206. PubMed ID: 25592241 [TBL] [Abstract][Full Text] [Related]
14. Psoriasis as a Predictor of Cardiometabolic Comorbidity in Women: A Study Based on the Danish National Birth Cohort. Blegvad C; Nybo Andersen AM; Adam A; Zachariae C; Skov L Acta Derm Venereol; 2019 Mar; 99(3):274-278. PubMed ID: 30460370 [TBL] [Abstract][Full Text] [Related]
15. Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Ormseth MJ; Lipson A; Alexopoulos N; Hartlage GR; Oeser AM; Bian A; Gebretsadik T; Shintani A; Raggi P; Stein CM Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1410-5. PubMed ID: 23592527 [TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss. Borel AL; Nazare JA; Baillot A; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E273-E281. PubMed ID: 28028035 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China. Ma L; Li M; Wang H; Li Y; Bai B Arch Dermatol Res; 2014 Apr; 306(3):247-51. PubMed ID: 24385235 [TBL] [Abstract][Full Text] [Related]